$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000117992915000068 Filed on May 07, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$3.171B	$2.069B
YoY Change	53.24%	30.11%
Cost Of Revenue	$2.672B	$1.762B
YoY Change	51.6%	32.73%
Gross Profit	$351.0M	$306.9M
YoY Change	14.37%	16.83%
Gross Profit Margin	11.07%	14.83%
Selling, General & Admin	$392.2M	$262.0M
YoY Change	49.69%	46.94%
% of Gross Profit	111.74%	85.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.00M	$32.99M
YoY Change	0.02%	51.36%
% of Gross Profit	9.4%	10.75%
Operating Expenses	$417.2M	$282.7M
YoY Change	47.58%	45.12%
Operating Profit	$82.00M	$24.00M
YoY Change	241.67%	-64.64%
Interest Expense	$15.00M	$13.82M
YoY Change	8.52%	6.02%
% of Operating Profit	18.29%	57.59%
Other Income/Expense, Net	-$15.00M	-$13.78M
YoY Change	8.87%	6.76%
Pretax Income	$67.00M	$10.49M
YoY Change	538.76%	-80.92%
Income Tax	$39.00M	$5.655M
% Of Pretax Income	58.21%	53.91%
Net Earnings	$28.00M	$4.000M
YoY Change	600.0%	-86.63%
Net Earnings / Revenue	0.88%	0.19%
Basic Earnings Per Share	$0.58	$0.10
Diluted Earnings Per Share	$0.56	$0.09
COMMON SHARES
Basic Shares Outstanding	49.00M shares	46.02M shares
Diluted Shares Outstanding	50.00M shares	47.52M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.074B	$1.780B
YoY Change	72.73%	17.74%
Cash & Equivalents	$1.870B	$1.083B
Short-Term Investments	$1.204B	$696.2M
Other Short-Term Assets	$193.5M	$112.9M
YoY Change	71.36%	185.31%
Inventory
Prepaid Expenses
Receivables	$491.4M	$338.2M
Other Receivables	$0.00	$28.10M
Total Short-Term Assets	$4.276B	$2.281B
YoY Change	87.42%	32.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$344.7M	$310.4M
YoY Change	11.07%	30.55%
Goodwill	$272.0M	$230.7M
YoY Change	17.9%	52.72%
Intangibles
YoY Change
Long-Term Investments		$10.90M
YoY Change		-19.85%
Other Assets	$34.06M	$39.73M
YoY Change	-14.26%	34.91%
Total Long-Term Assets	$894.2M	$1.012B
YoY Change	-11.66%	33.01%
TOTAL ASSETS
Total Short-Term Assets	$4.276B	$2.281B
Total Long-Term Assets	$894.2M	$1.012B
Total Assets	$5.170B	$3.293B
YoY Change	56.97%	32.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$427.6M	$406.4M
YoY Change	5.22%	154.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$440.6M	$183.7M
YoY Change	139.85%	15642.33%
Total Short-Term Liabilities	$3.593B	$1.556B
YoY Change	130.93%	93.76%
LONG-TERM LIABILITIES
Long-Term Debt	$472.0M	$615.6M
YoY Change	-23.33%	-4.11%
Other Long-Term Liabilities	$33.35M	$27.74M
YoY Change	20.24%	16.35%
Total Long-Term Liabilities	$33.35M	$27.74M
YoY Change	20.24%	-95.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.593B	$1.556B
Total Long-Term Liabilities	$33.35M	$27.74M
Total Liabilities	$4.128B	$2.396B
YoY Change	72.3%	38.97%
SHAREHOLDERS EQUITY
Retained Earnings	$643.5M	$557.6M
YoY Change	15.4%	5.19%
Common Stock	$398.1M	$340.4M
YoY Change	16.95%	45.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.042B	$897.7M
YoY Change
Total Liabilities & Shareholders Equity	$5.170B	$3.293B
YoY Change	56.97%	32.37%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	$28.00M	$4.000M
YoY Change	600.0%	-86.63%
Depreciation, Depletion And Amortization	$33.00M	$32.99M
YoY Change	0.02%	51.36%
Cash From Operating Activities	$554.0M	$210.9M
YoY Change	162.69%	949.03%
INVESTING ACTIVITIES
Capital Expenditures	-$25.00M	-$17.80M
YoY Change	40.45%	58.93%
Acquisitions	$8.000M	$0.00
YoY Change
Other Investing Activities	$7.000M	$547.0K
YoY Change	1179.71%	-105.47%
Cash From Investing Activities	-$228.0M	-$27.49M
YoY Change	729.36%	29.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net		$0.00
YoY Change		-100.0%
Cash From Financing Activities	$5.000M	-$35.93M
YoY Change	-113.92%	-109.59%
NET CHANGE
Cash From Operating Activities	$554.0M	$210.9M
Cash From Investing Activities	-$228.0M	-$27.49M
Cash From Financing Activities	$5.000M	-$35.93M
Net Change In Cash	$331.0M	$147.5M
YoY Change	124.45%	-60.54%
FREE CASH FLOW
Cash From Operating Activities	$554.0M	$210.9M
Capital Expenditures	-$25.00M	-$17.80M
Free Cash Flow	$579.0M	$228.7M
YoY Change	153.17%	630.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50132000	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
CY2015Q1	dei	Trading Symbol TradingSymbol	moh
CY2014Q1	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	6674000	USD
CY2015Q1	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	7290000	USD
CY2014Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	7600000	USD
CY2015Q1	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	17300000	USD
CY2014Q4	moh	Capitation Claims Payable CapitationClaimsPayable	28150000	USD
CY2015Q1	moh	Capitation Claims Payable CapitationClaimsPayable	47171000	USD
CY2015Q1	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2015Q1	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2014Q1	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	22190000	USD
CY2015Q1	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	40778000	USD
CY2014Q1	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	18696000	USD
CY2015Q1	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	47948000	USD
CY2014Q1	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	51693000	USD
CY2015Q1	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	95347000	USD
CY2015Q1	moh	Health Care Organization Prior Year Claimsand Claims Adjustment Medical Provision Expense HealthCareOrganizationPriorYearClaimsandClaimsAdjustmentMedicalProvisionExpense	-25000000	USD
CY2014Q1	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	43265000	USD
CY2015Q1	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	94965000	USD
CY2014Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	160710000	USD
CY2015Q1	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	161013000	USD
CY2015Q1	moh	Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService	P2Y
CY2014Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	119300000	USD
CY2015Q1	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	105400000	USD
CY2014	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-31973000	USD
CY2015Q1	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-13914000	USD
CY2014Q4	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	527193000	USD
CY2015Q1	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	622158000	USD
CY2014Q4	moh	Other Claims Payable OtherClaimsPayable	230531000	USD
CY2015Q1	moh	Other Claims Payable OtherClaimsPayable	226878000	USD
CY2014Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	71412000	USD
CY2015Q1	moh	Pharmacy Claims Payable PharmacyClaimsPayable	84180000	USD
CY2014	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.069
CY2015Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.113
CY2014	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.006
CY2015Q1	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.015
CY2014	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.005
CY2015Q1	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.014
CY2014Q1	moh	Premium Tax Expenses PremiumTaxExpenses	51693000	USD
CY2015Q1	moh	Premium Tax Expenses PremiumTaxExpenses	95347000	USD
CY2015Q1	moh	Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation	2100000	USD
CY2014Q1	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	150000	shares
CY2015Q1	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	107000	shares
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	241654000	USD
CY2015Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	427644000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8987000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10836000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1019000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	297000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	396059000	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	398141000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5596000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5675000	USD
CY2014Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6314000	USD
CY2015Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6986000	USD
CY2014Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	859000000	USD
CY2015Q1	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	928000000	USD
CY2014Q4	us-gaap	Assets Assets	4477215000	USD
CY2015Q1	us-gaap	Assets Assets	5169789000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	3245397000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	4275570000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1025951000	USD
CY2015Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1206195000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1024309000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1206666000	USD
CY2008Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	82100000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	395000	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1440000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2037000	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	969000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	598000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	404000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1439000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	565000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	539475000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	412375000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	47576000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	82519000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	7331000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	7339000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	601243000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	601953000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	3000000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	2800000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935895000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1083369000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	594621000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	594574000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1206666000	USD
CY2014Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	416	Security
CY2015Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	271	Security
CY2014Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	32	Security
CY2015Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	46	Security
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1539063000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1870024000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	147474000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	330961000	USD
CY2015Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49727000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49908000	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2015Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5202000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29469000	USD
CY2014Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	7775000	USD
CY2015Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	704097000	USD
CY2015Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	270836000	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	2044976000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	3088893000	USD
CY2014Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	53675000	USD
CY2015Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	57314000	USD
CY2015Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	704097000	USD
CY2015Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	711084000	USD
CY2014Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2015Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	147454000	USD
CY2015Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	140467000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	196076000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	169811000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	39532000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	42631000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	24271000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	29267000	USD
CY2014Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20691000	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24992000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32994000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32574000	USD
CY2014Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	USD
CY2015Q1	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	474121000	USD
CY2014Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	329323000	USD
CY2015Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	0	USD
CY2014Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2000	USD
CY2015Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	9000	USD
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2015Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	473983000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	329194000	USD
CY2015Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2014Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	40241000	USD
CY2015Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	40135000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2014Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2015Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	82000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89273000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	84702000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	188087000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	256090000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	271964000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	272046000	USD
CY2014Q1	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	3258000	USD
CY2015Q1	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	2303000	USD
CY2014Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1940337000	USD
CY2015Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2970652000	USD
CY2015Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	101366000	USD
CY2015Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5271000	USD
CY2015Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	5265000	USD
CY2015Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	96103000	USD
CY2015Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	96101000	USD
CY2015Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	101374000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4834000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	28141000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	10489000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	67364000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.11
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.58
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.56
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.10
CY2014Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	149754000	USD
CY2015Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	247610000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	78023000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137278000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-336000	USD
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	12000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5655000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39223000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	58952000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	189373000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4642000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1849000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	670000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1097000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	24060000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-26265000	USD
CY2014Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	39297000	USD
CY2015Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-105026000	USD
CY2014Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	14381000	USD
CY2015Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	4612000	USD
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	918000	shares
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	902000	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	597000	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	468000	shares
CY2014Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1629000	USD
CY2015Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	3015000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	13822000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	14876000	USD
CY2014Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	9614000	USD
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	9758000	USD
CY2014Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3300000	USD
CY2015Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2772000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3466773000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	4127796000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4477215000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5169789000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2174773000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3593196000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	669787000	USD
CY2014Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1200522000	USD
CY2015Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1448132000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	7064427000	USD
CY2015Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	1647981000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	449771000	USD
CY2015Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	726250000	USD
CY2014Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	870429000	USD
CY2015Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1089903000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	8076906000	USD
CY2015Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	2635755000	USD
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	851551000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	341000	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	440632000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	851551000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1019462000	USD
CY2015Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1203866000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35932000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5118000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27491000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-227790000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	210897000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	553633000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	4498000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	28153000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13778000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14866000	USD
CY2015Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	24267000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	82230000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	50884000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	193498000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44326000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34064000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1300000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	704000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1316000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1426000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2116000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	722000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	800000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33487000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33349000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000	USD
CY2014Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1548000	USD
CY2015Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3564000	USD
CY2014	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	7514198000	USD
CY2015Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	2374231000	USD
CY2014Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	547000	USD
CY2015Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7216000	USD
CY2014Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	38119000	USD
CY2015Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2014Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2015Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8006000	USD
CY2014Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	142145000	USD
CY2015Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	438591000	USD
CY2014Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	17788000	USD
CY2015Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	24974000	USD
CY2014Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1721658000	USD
CY2015Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2635784000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1330000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1089000	USD
CY2014Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	857000	USD
CY2015Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	4029000	USD
CY2014Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	147370000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	255609000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	340778000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344727000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	596456000	USD
CY2015Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	491430000	USD
CY2014Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	102479000	USD
CY2015Q1	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	101366000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	615352000	USD
CY2015Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	51858000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47520000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50071000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46021000	shares
CY2015Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	35902000	USD
CY2014Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	53630000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48685000	shares
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	643505000	USD
CY2015Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	581000000	USD
CY2014Q1	us-gaap	Stock Issued1 StockIssued1	8217000	USD
CY2015Q1	us-gaap	Stock Issued1 StockIssued1	8774000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1010442000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	1041993000	USD
CY2015Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	31600000	USD
CY2014Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2015Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	7924000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	8122885000	USD
CY2015Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	2771588000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-45979000	USD
CY2015Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-135833000	USD
CY2014Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	40657000	USD
CY2014Q1	us-gaap	Revenues Revenues	2069243000	USD
CY2015Q1	us-gaap	Revenues Revenues	3171123000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5596000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5675000	USD
CY2013Q4	us-gaap	Shares Outstanding SharesOutstanding	45871000	shares
CY2014Q4	us-gaap	Shares Outstanding SharesOutstanding	48578000	shares
CY2015Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	987000000	USD
CY2015Q1	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,089,903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84,180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,412</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226,878</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,448,132</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name	View Source	Status
0001179929-15-000068-index-headers.html	Edgar Link	pending
0001179929-15-000068-index.html	Edgar Link	pending
0001179929-15-000068.txt	Edgar Link	pending
0001179929-15-000068-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
moh-03312015x10q.htm	Edgar Link	pending
moh-03312015x10qex311.htm	Edgar Link	pending
moh-03312015x10qex312.htm	Edgar Link	pending
moh-03312015x10qex321.htm	Edgar Link	pending
moh-03312015x10qex322.htm	Edgar Link	pending
moh-20150331.xml	Edgar Link	completed
moh-20150331.xsd	Edgar Link	pending
moh-20150331_cal.xml	Edgar Link	unprocessable
moh-20150331_def.xml	Edgar Link	unprocessable
moh-20150331_lab.xml	Edgar Link	unprocessable
moh-20150331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2015 Q1 Form 10-Q Financial Statement

#000117992915000068 Filed on May 07, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2015 Q1 Form 10-Q Financial Statement

#000117992915000068 Filed on May 07, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh